Corporate Information

Community & Education > Lustgarten Foundation

The Lustgarten Foundation for Pancreatic Cancer Research

Cablevision Systems Corporation is dedicated to advancing The Lustgarten Foundation's efforts to increase research for pancreatic cancer, the most lethal of all cancers. Cablevision underwrites the Foundation's administrative expenses, so that 100% of every donation to the Foundation goes directly to pancreatic cancer research.

Cablevision's fight to defeat pancreatic cancer began in 1998. At that time, Marc Lustgarten, the former vice chairman of Cablevision and chairman of The Madison Square Garden Company, together with Cablevision Chairman Charles Dolan and Chief Executive James Dolan, established The Lustgarten Foundation. Mr. Lustgarten died from pancreatic cancer in 1999.

Today, The Lustgarten Foundation is the nation's largest private foundation dedicated to funding pancreatic cancer research aimed at detecting the disease earlier, developing better treatments, and ultimately, finding a cure. Cablevision and The Lustgarten Foundation are also partners in curePC, an award-winning public service campaign that uses Cablevision's media and entertainment properties to raise awareness of pancreatic cancer and of the Foundation's efforts in the battle against this deadly disease.

Pancreatic cancer is swift and silent, often undetected until it's too late. More than 40,000 people will die from it this year. The overall five-year survival rate for pancreatic cancer is seven percent and most with advanced cancer die within a year. There are no early detection tests, no effective long-term treatments and, unless the cancer is surgically removed in its earliest stages, no cure.

The Lustgarten Foundation is committed to changing these facts, and as a result of research funded by the Foundation:

  • The genetic makeup of this cancer is better known today than ever before.
  • Research to identify and develop new therapies is now underway.
  • Early detection tests are being developed.
  • Immunotherapies are being tested for treating pancreatic cancer.
  • More clinical trials are available for pancreatic cancer.
  • Families are being examined to determine which genes cause hereditary pancreatic cancer.

With only two percent of federal funding directed at researching the nation's fourth-leading cause of cancer deaths, The Lustgarten Foundation's efforts have led to a substantially better understanding of pancreatic cancer and to successfully advancing research to find a cure. Please join Cablevision and The Lustgarten Foundation in the fight against pancreatic cancer. Visit and learn how you can help defeat this deadly disease.

Stock Info:

Cablevision Stock Quote
minimum 20 minute delay